Hosted on MSN11mon
Biotech Group Voices Support for US Curbs on China as WuXi Exitshas gone from trying to water down proposed US legislation to sever ties with Chinese health care companies, to supporting it. Controversy caused by the Biosecure Act recently led to WuXi AppTec ...
Hong Kong IPO: WuXi Biologics unit eyes up to US$520 million in biotech push WuXi XDC, a 60 per cent-owned unit of WuXi Biologics, could raise as much as US$520 million, including excess share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback